“There is no approved treatment for Long COVID (aka Long Haulers) and there are very few clinical trials for the debilitating condition, but Pfizer (PFE) and Todos Medical (TOMDF) might have stumbled onto a solution that could not only help the sufferers but also help pull the United States economy out of the current downturn.”

We think this is interesting on several levels.

We have not commented on this small monoclonal antibody before. It is the property of a small company in Vancouver, Washington called Cytodyne. The antibody is an immune system modulator and is apparently effective in reducing the effects of a cytokine storm produced by the body as a reaction to the damage done by COVID-19.